Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zehra E. Cobanoglu"'
Autor:
Ibrahim Tekedereli, S Neslihan Alpay, Clint D J Tavares, Zehra E Cobanoglu, Tamer S Kaoud, Ibrahim Sahin, Anil K Sood, Gabriel Lopez-Berestein, Kevin N Dalby, Bulent Ozpolat
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41171 (2012)
Eukaryotic elongation factor 2 kinase (eEF-2K), through its phosphorylation of elongation factor 2 (eEF2), provides a mechanism by which cells can control the rate of the elongation phase of protein synthesis. The activity of eEF-2K is increased in r
Externí odkaz:
https://doaj.org/article/7b1050ea3c5247ddb961e153def8c789
Autor:
Dean A. Lee, Brian A Geier, Anish K Ray, Srinivas S. Somanchi, Zehra E. Cobanoglu, Arianexys Aquino-Lopez, Neda Dastgheyb
Publikováno v:
Pediatric bloodcancerREFERENCES. 66(10)
Natural killer (NK) cells have potential utility in pediatric cancer immunotherapy for their ability to lyse diverse tumor targets, lack of dependence on mutation-associated tumor antigens, and for their relative safety demonstrated so far in clinica
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(2)
Autor:
Gabriel Lopez-Berestein, Anil K. Sood, Kevin N. Dalby, Ibrahim Halil Sahin, Zehra E. Cobanoglu, S. Neslihan Alpay, Tamer S. Kaoud, Clint D.J. Tavares, Bulent Ozpolat, Ibrahim Tekedereli
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 7, p e41171 (2012)
PLoS ONE, Vol 7, Iss 7, p e41171 (2012)
Eukaryotic elongation factor 2 kinase (eEF-2K), through its phosphorylation of elongation factor 2 (eEF2), provides a mechanism by which cells can control the rate of the elongation phase of protein synthesis. The activity of eEF-2K is increased in r
Autor:
Ray, Anish K., Somanchi, Srinivas S., Dastgheyb, Neda, Aquino‐Lopez, Arianexys, Cobanoglu, Zehra E., Geier, Brian, Lee, Dean A., Aquino-Lopez, Arianexys
Publikováno v:
Pediatric Blood & Cancer; Oct2019, Vol. 66 Issue 10, pN.PAG-N.PAG, 1p